Diabetes Care
29:2244-2246,
2006
DOI: 10.2337/dc06-0946
© 2006 by the American Diabetes Association
Clinical Care/Education/Nutrition Original Article |
Vitamin D Status and Glucose Homeostasis in the 1958 British Birth Cohort
The role of obesity
Elina Hyppönen, PHD and
Chris Power, PHD
From the Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London, U.K
Address correspondence and reprint requests to Dr. Elina Hyppönen, Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, 30 Guildford St., London, WC1N 1EH, U.K. E-mail: e.hypponen{at}ich.ucl.ac.uk
OBJECTIVEObesity is a well-known risk factor for vitamin D deficiency. We evaluated the interrelationship between vitamin D status, body size, and glucose homeostasis, measured by HbA1c (A1C).
RESEARCH DESIGN AND METHODSData are from the survey of the 45-year-old 1958 British birth cohort (20022004). Information on A1C, 25-hydroxyvitamin D [25(OH)D; an indicator of vitamin D status], and BMI was collected from 7,198 Caucasian subjects.
RESULTS25(OH)D was <75 nmol/l in 80% of the obese subjects (BMI 30 kg/m2) versus 68% of the other subjects (P < 0.0001). Serum 25(OH)D decreased and A1C increased by increasing BMI (P < 0.0001 for both comparisons). There was a nonlinear association between 25(OH)D and A1C: a steep linear decrease in A1C by 25(OH)D until 65 nmol/l and only smaller decreases with further increases. There was evidence for effect modification by BMI in the association between 25(OH)D and A1C (P < 0.0001), and differences appeared stronger for participants with higher compared with lower BMIs. After adjustment for sex, season, geographical location, physical activity, and social class, percent change in A1C by 10-nmol/l increase in 25(OH)D was 0.21 (95% CI 0.31 to 0.11) for BMI <25 kg/m2, 0.25 (0.37 to 0.13) for BMI 2529.9 kg/m2, 0.65 (0.95 to 0.34) for BMI 3034.9 kg/m2, and 1.37 (2.09 to 0.64) for BMI 35 kg/m2.
CONCLUSIONSBody size was a strong determinant for 25(OH)D, with concentrations being suboptimal in most obese participants. Randomized controlled trials [using dosages sufficient to improve 25(OH)D also for the obese] are required to determine whether clinically relevant improvements in glucose metabolism can be obtained by vitamin D supplementation.
Abbreviations: 25(OH)D, 25-hydroxyvitamin D

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K Atherton, E Fuller, P Shepherd, D P Strachan, and C Power
Loss and representativeness in a biomedical survey at age 45 years: 1958 British birth cohort
J. Epidemiol. Community Health,
March 1, 2008;
62(3):
216 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T Aasheim, D. Hofso, J. Hjelmesaeth, K. I Birkeland, and T. Bohmer
Vitamin status in morbidly obese patients: a cross-sectional study
Am. J. Clinical Nutrition,
February 1, 2008;
87(2):
362 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hypponen, B. J. Boucher, D. J. Berry, and C. Power
25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age: A Cross-Sectional Study in the 1958 British Birth Cohort
Diabetes,
February 1, 2008;
57(2):
298 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hypponen, S. Turner, P. Cumberland, C. Power, and I. Gibb
Serum 25-Hydroxyvitamin D Measurement in a Large Population Survey with Statistical Harmonization of Assay Variation to an International Standard
J. Clin. Endocrinol. Metab.,
December 1, 2007;
92(12):
4615 - 4622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Bodnar, J. M. Catov, J. M. Roberts, and H. N. Simhan
Prepregnancy Obesity Predicts Poor Vitamin D Status in Mothers and Their Neonates
J. Nutr.,
November 1, 2007;
137(11):
2437 - 2442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Harris and B. Dawson-Hughes
Reduced Sun Exposure Does Not Explain the Inverse Association of 25-Hydroxyvitamin D with Percent Body Fat in Older Adults
J. Clin. Endocrinol. Metab.,
August 1, 2007;
92(8):
3155 - 3157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2017 - 2029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Caan, M. Neuhouser, A. Aragaki, C. B. Lewis, R. Jackson, M. S. LeBoff, K. L. Margolis, L. Powell, G. Uwaifo, E. Whitlock, et al.
Calcium Plus Vitamin D Supplementation and the Risk of Postmenopausal Weight Gain
Arch Intern Med,
May 14, 2007;
167(9):
893 - 902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vieth, H. Bischoff-Ferrari, B. J Boucher, B. Dawson-Hughes, C. F Garland, R. P Heaney, M. F Holick, B. W Hollis, C. Lamberg-Allardt, J. J McGrath, et al.
The urgent need to recommend an intake of vitamin D that is effective
Am. J. Clinical Nutrition,
March 1, 2007;
85(3):
649 - 650.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hypponen and C. Power
Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors
Am. J. Clinical Nutrition,
March 1, 2007;
85(3):
860 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Michos and R. S. Blumenthal
Vitamin D Supplementation and Cardiovascular Disease Risk
Circulation,
February 20, 2007;
115(7):
827 - 828.
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|